
[TimAlerts] HTBX Because it just put out some data from its lead bladder cancer trial, and things don’t look great. Essentially, the drug looked like it might work, and then didn’t. http://www.insidermonkey.com/blog/biotech-movers-heat-biologics-inc-htbx-and-achaogen-inc-akao-496237/?yptr=yahoo

[TimAlerts] $FNMA going down

[TimAlerts] $NAVB the level 2 is so manipulated in here

[TimAlerts] $NAVB i think is waking up

[TimAlerts] $NAVB, yeah... they are getting like $80 mil upfront in cash, and potential $200 mil down the road in royalty payments. The whole company has only 120mil market cap, so.... solid news.

[TimAlerts] $NAVB pretty good earnings released on 17 nov and now this agreement, would the breakout be at 1.14ish ?